Abstract
Systemic embolism has long been recognized as a major complication of valvular heart disease, specifically mitral valve disease. In the absence of mitral valve disease or atrial fibrillation (AF), clinically detectable systemic emboli are uncommon in patients with isolated aortic valve disease (1).
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Levine HJ, Pauker SG, Salzman EW: Antithrombotic therapy In valvular heart disease. Chest 89, Feb. Supplement, 36S, 1986.
Dalen JE: Mitral stenosis. In: Dalen JE, Alpert JS, eds. Valvular Heart Disease, Second Edition, Boston, MA: Little, Brown and Co., 49:1986.
Coulshed N, Epstein EJ, McKendrick CS, Galloway RW, Walker E: Systemic embolism in mitral valve disease. Br Heart J 32:26, 1970.
Ellis LB, Harken DE: Arterial embolization in relation to mitral valvuloplasty. Am Heart J 62:611, 1961.
Bannister RG: The risks of deferring valvotomy in patients with moderate mitral stenosis. Lancet 2:329, 1960.
Weiss S, Davis D: Rheumatic heart disease. III. Embolic manifestations. Amer Heart J 9:45, 1933.
Graham GK, Taylor JA, Ellis LB, Greenberg DJ, Robbins SL: Studies in mitral stenosis. Arch Int Med 88:632, 1951.
Rowe JC: The course of mitral stenosis without surgery: Ten- and twenty-year perspectives. Ann Intern Med 52:741, 1960.
Olesen KH: The natural history of 271 patients with mitral stenosis under medical treatment. Br Heart J 24:349, 1962.
Sherrid MV, Clark RD, Cohn K: Echocardiographic analysis of left atrial size before and after operation in mitral valve disease. Am J Cardiol 43:171, 1979.
Wood P: Diseases of the heart and circulation. Philadelphia: JB Lippincott Co, 1956.
Barnett HJM: Transient cerebral ischemic: pathogenesis, prognosis and management. Ann R Coll Physicians Surg Can 7:153, 1974.
Barnett HJM, Jones ME, Boughner DR, Kostuk WJ: Cerebral ischemic events associated with prolapsing mitral valve. Arch Neurol 33:777, 1976.
Hirsowitz GS, Saffer D: Hemiplegia and the billowing mitral leaflet syndrome. J Neurol Neurosurg Psychiatry 41:381, 1978.
Saffro R, Talano JV: Transient ischemic attack associated with mitral systolic clicks. Arch Intern Med 139:693, 1979.
Hanson MR, Hodgman JR, Conomy JP: A study of stroke associated with prolapsed mitral valve. Neurology 23:341, 1978.
Barnett HJM, Boughner DR, Taylor DW: Further evidence relating mitral valve prolapse to cerebral ischemic events. N Engl J Med 302:139, 1980.
ACCP-NHLBI National Conference on Antithrombotic Therapy. Dalen JE, Hirsch J, editors. Chest 89, February Supplement, 1986.
Pape LA: Pathogenesis and etiology of valvular heart disease. In: Dalen JE, Alpert JS, eds. Valvular Heart Disease, Second Edition, Boston, MA: Little, Brown and Co., 1, 1986.
Guthrie JJ, Fairgrieve JJ: Aortic embolism due to a myxoid tumor associated with myocardial calcification. Br Heart J 25:137, 1963.
Fulkerson PK, Beaver BM, Auseon J, Graber HL: Calcification of the mitral annulus: etiology, clinical associations, complications and therapy. Am J Med 66:967, 1979.
Kaiman P, DePace NL, Kotler MN, et al: Mitral annular calcification and echogenic densities in the left ventricuar outflow tract in association with cerebral ischemic events. J Cardiovasc Ultrasonogr 1:155, 1982.
Duvoisin GE, Brandenburg RO, McGoon DC: Factors affecting thromboembolism associated with prosthetic heart valves. Circulation Supplement 1:70, 1967.
Akbarian M, Austen WG, Yurchak PM, Scanneil JG: Thromboembolic complications of prosthetic cardiac valves. Circulation 37:826, 1968.
Stein DW, Rahimtoola SH, Kloster FE, Seiden R, Starr A: Thrombotic phenomena with nonanticoagulated, composite-strut aortic prostheses. J Thoracic Cardiovasc Surg 71:680, 1976.
Bjork VO, Henze A: Management of thromboembolism after aortic valve replacement with the Bjork-Shiley tilting disc valve. Scand J Thorac Cardiovasc Surg 9:183, 1975.
Stein PD, Collins JJ Jr, Kantrowitz A: Antithrombotic therapy in mechanical and biological prosthetic heart valves and saphenous vein bypass grafts. Chest 89, February Supplement 46S, 1986.
Starr A, Grunkemeier G, Lambert L, Okies JE, Thomas D: Mitral valve replacement. Circulation 54:47 (Suppl III), 1976.
Salomon NW, Stinson EB, Griepp RB, Shumway NE: Mitral valve replacement: long-term evaluation of prosthesis-related mortality and morbidity. Circulation 56:94, 1977.
Edmunds LH: Thromboembolic complications of current cardiac valvular prostheses. Ann Thorac Surg 34:96, 1982.
Ionescu MI, Smith DR, Hasan SS, Chidambaram M, Tandon AP: Clinical durability of the pericardial xenograft valve: Ten years experience with mitral replacement. Ann Thorac Surg 34:265, 1982.
Oyer PE, Stinson EB, Griepp RB, Shumway NE: Valve replacement with the Starr-Edwards and Hancock prostheses: comparative analysis of late morbidity and mortality. Ann Surg 186:301, 1977.
Nunez L, Gil Aguado M, Larrea JL: Prevention of thromboembolism using aspirin after mitral valve replacement with porcine bioprosthesis. Ann Thorac Surg 37:84, 1984.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1987 Springer Science+Business Media New York
About this chapter
Cite this chapter
Dalen, J.E. (1987). Arterial Thromboembolism: Valvular Heart Disease and Prosthetic Heart Valves. In: Wessler, S., Becker, C.G., Nemerson, Y. (eds) The New Dimensions of Warfarin Prophylaxis. Springer, Boston, MA. https://doi.org/10.1007/978-1-4757-5985-3_25
Download citation
DOI: https://doi.org/10.1007/978-1-4757-5985-3_25
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4757-5987-7
Online ISBN: 978-1-4757-5985-3
eBook Packages: Springer Book Archive